1) late-course hyperfractionated accelerated radiation therapy
后程加速超分割照射
2) Late course accelerated hyperfractionation
后程加速超分割
1.
Purpose: A prospective randomized clinical trial was conducted to compare the effect of late course accelerated hyperfractionation(LCAHF) with that of conventional fractionation(CF) in the treatment of nasopharyngeal carcinoma(NPC).
目的 :探讨后程加速超分割能否较常规分割具有更好的鼻咽原发灶局部控制率 ,相应地提高生存率。
2.
Conclusion:Late course accelerated hyperfractionation with 3-DCRT conformal radiotherapy combined concurrent chemotherapy is effective and well tolerated in the patients with esophageal carcinoma.
目的:评价三维适形(3DCRT)后程加速超分割放疗同步氟尿嘧啶+顺铂化疗食管癌的局部控制率,生存期和毒副作用。
3) late course accelerated hyperfraction
后程加速超分割
1.
Effects of late course accelerated hyperfraction on esophageal carcinoma;
后程加速超分割放射治疗食管癌结果分析
2.
Objective To evaluate the clinical value of late course accelerated hyperfractionation radiotherapy(LCAH) in stage Ⅲ non-small cell lung cancer(NSCLC).
目的探讨后程加速超分割放射治疗非小细胞肺癌的临床价值。
4) late course accelerated fractionation
后程加速超分割
1.
The study of 45 esophageal carcinoa patients treated by late course accelerated fractionation radiotherapy;
45例食管癌后程加速超分割放疗的疗效
2.
Late course accelerated fractionation radiotherapy for advanced squamous cell carcinoma of the lung;
后程加速超分割放射治疗中晚期肺鳞癌的临床研究
5) late-course accelerated hyperfractionation
后程加速超分割
1.
Objective:To discuss the effect in treatment of esophageal carcinoma by late-course accelerated hyperfractionation radiotherapy.
目的:探讨后程加速超分割放射治疗食管癌的疗效。
2.
Conclusion Late-course accelerated hyperfractionation radiotherapy plus paclitaxel for locally advanced nasopharyngeal carcinoma have a good short-term efficacy, moderate toxicity; patients can easily tolerate.
目的探讨后程加速超分割放疗加紫杉醇治疗局部晚期鼻咽癌的近期疗效和毒副反应。
6) Late course accelerated hyperfractionation radiotherapy
后程加速超分割放射治疗
1.
ObjectiveTo compare the toxic reaction,therapeutic effect and survival rate between neoadjuvent-chemotherapy and concurrent-chemotherapy while late course accelerated hyperfractionation radiotherapy being taken for advanced NPC.
方法 3 2例中晚期鼻咽癌应用羟基喜树碱 (HCTP)诱导化疗联合后程加速超分割放射治疗 ,48例类似病人应用DDP加 5 Fu化疗同期联合后程加速超分割放射治疗。
补充资料：照射量与照射量率
分子式：
CAS号：
性质：照射量是指X或γ射线在质量为dm的一个体积元内，当光子产生的全部电子都被阻留在空气中所形成的一种符号的离子总电荷的绝对值dQ、除以dm，即照射量X=dQ/dm。SI单位为库仑每千克(c/kg)。专用单位为伦琴(R)，1R=2.58×10-4C/kg。照射量率定义为单位时间内的照射量。用X表示，X=dX/dt，式中dx为dt时间内照射量的增量。单位为库仑每千克秒[C/(kg·s)]。
CAS号：
性质：照射量是指X或γ射线在质量为dm的一个体积元内，当光子产生的全部电子都被阻留在空气中所形成的一种符号的离子总电荷的绝对值dQ、除以dm，即照射量X=dQ/dm。SI单位为库仑每千克(c/kg)。专用单位为伦琴(R)，1R=2.58×10-4C/kg。照射量率定义为单位时间内的照射量。用X表示，X=dX/dt，式中dx为dt时间内照射量的增量。单位为库仑每千克秒[C/(kg·s)]。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条